Source:http://linkedlifedata.com/resource/pubmed/id/10453038
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-9-14
|
pubmed:abstractText |
Macrolide antibiotics have unique immunomodulatory actions apart from antimicrobial properties. We studied the effects of macrolides on IgG immune complex (IgG-ICx)-induced lung injury in rats in vivo and in vitro. Intrapulmonary deposition of IgG-ICx produced a time-dependent increase in the concentration of NO in exhaled air. There were corresponding increases in the number of neutrophils accumulated into alveolar spaces, and lung wet-to-dry weight ratio. All of these changes were inhibited by pretreatment with erythromycin or josamycin, but not by amoxicillin or cephaclor. Incubation of cultured pulmonary alveolar macrophages caused up-regulation of NO production and expression of inducible NO synthase mRNA, an effect that was dose dependently inhibited by erythromycin, roxithromycin, or josamycin. The macrolides also reduced IgG-ICx-induced release of IL-1beta and TNF-alpha, but did not alter the release of NO induced by exogenously added IL-1beta and TNF-alpha. These results suggest that macrolide antibiotics specifically inhibit immune complex-induced lung injury presumably by inhibiting cytokine release and the resultant down-regulation of inducible NO synthase gene expression and NO production by rat pulmonary alveolar macrophages.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antigen-Antibody Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Erythromycin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II,
http://linkedlifedata.com/resource/pubmed/chemical/Nos2 protein, rat
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2909-15
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10453038-Animals,
pubmed-meshheading:10453038-Anti-Bacterial Agents,
pubmed-meshheading:10453038-Antigen-Antibody Complex,
pubmed-meshheading:10453038-Breath Tests,
pubmed-meshheading:10453038-Cells, Cultured,
pubmed-meshheading:10453038-Cytokines,
pubmed-meshheading:10453038-Erythromycin,
pubmed-meshheading:10453038-Gene Expression Regulation,
pubmed-meshheading:10453038-Lung,
pubmed-meshheading:10453038-Macrophages, Alveolar,
pubmed-meshheading:10453038-Male,
pubmed-meshheading:10453038-Nitric Oxide,
pubmed-meshheading:10453038-Nitric Oxide Synthase,
pubmed-meshheading:10453038-Nitric Oxide Synthase Type II,
pubmed-meshheading:10453038-Rats,
pubmed-meshheading:10453038-Rats, Sprague-Dawley
|
pubmed:year |
1999
|
pubmed:articleTitle |
Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages.
|
pubmed:affiliation |
First Department of Medicine, Tokyo Women's Medical University School of Medicine, Japan. jtamaoki@xc4.so-net.ne.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|